• Journal of Ginseng Research
• /
• v.23 no.3 s.55
• /
• pp.172-175
• /
• 1999

The effect of Korean red ginseng extract on the pharmacokinetics of ethanol was examined in 14 male rats and 10 healthy male volunteers. Aqueous red ginseng extract (200 mg/kg), or an equivalent volume of water was administered orally to the rats and followed immediately by treatment with $50\%$ (v/v) ethanol orally (3.2 g/kg). The area under the curve (AVC) and elimination rate constant (Ke) of ethanol were $29.2{\pm}6.2\;g{\cdot}min{\cdot}dl^{-},\;0.51{\pm}0.06\;mg{\cdot}dl^{-}{\cdot}min.^{-}$ in ginseng-treated group and $28.0{\pm}5.6\;g{\cdot}min.{\cdot}dl^{-},0.5{\pm}0.1\;mg{\cdot}dl^{-}{\cdot}min.^{-}$ in control group. These differences were not significant. The volunteers were given orally with 3g of aqueous ginseng, or an equivalent volume of water, followed immediately by Korean alcoholic beverage, Soju (2.4 ml/kg). The AUC and Ke of ethanol for volunteers were $10.6{\pm}2.0\;g{\cdot}min.{\cdot}dl^{-}$ and $0.21{\pm}0.05\;mg{\cdot}dl^{-}{\cdot}min.^{-}$ in ginseng-treated group and $11.0{\pm}2.2\;g{\cdot}min.{\cdot}dl^{-}$ and $0.22{\pm}0.04\;mg{\cdot}dl^{-}{\cdot}min.^{-}$ in control group. These differences were not also significant. These results suggest that an application of red ginseng extract does not have any clinically significant effect on the pharmacokinetics of ethanol.

• Korean Journal of Veterinary Research
• /
• v.35 no.3
• /
• pp.471-480
• /
• 1995

The purpose of this experiment was to develop a simple and reliable HPLC method for the detection of ciprofloxacin in chicken serum and to provide a basic data on pharmacokinetic parameters after oral and intramuscular administration. The results obtained were as follows: 1. 0.2% meta-phosphoric acid: acetonitrile(7:3, v/v) solution had a high and regular recovery rates and was selected as an extraction solution. 2. The recovery rates of ciprofloxacin were 83-97% with the selected solution in chicken serum and the detection limit was 50ng/ml in serum. 3. Ka(abosorption rate constant) were 3.652 1/h in fasted group and 0.880 1/h in non-fasted group, and Ke (elimination rate constant) were 0.061 1/h and 0.133 1/h, respectively. 4. The highest concentration in serum after intramuscular injection was 840ng/ml within 15-30min and 160-324ng/ml in 1.1-3.2 hours after oral administration. 5. The time course of blood concentration fits well into a 2 compartment model. 6. On oral administration of ciprofloxacin with feed, ciprofloxacin was absorbed more slowly and the amount of absorbed was smaller than that of in fasted chickens. 7. Blood concentration of ciprofloxacin increased in a dose-dependent manner after intramusclular and oral administraiton.

• Tuberculosis and Respiratory Diseases
• /
• v.47 no.4
• /
• pp.442-450
• /
• 1999

Background : Isoniazid(INH) and rifampicin(RFP) are the most effective anti-tuberculosis drugs which make the short-course chemotherapy possible. Although prescribed dosages of INH and RFP in Korea are different from those recommended by American Thoracic Society, there has been few study about pharmacokinetic profiles of INH and RFP in Korean patients who receive INH, RFP, ethambutol(EMB) and pyrazinamide(PZA) simultaneously. Methods : Among the patients with active tuberculosis from Dec. 1997 to July 1998, we selected 17 patients. After an overnight fast, patients were given INH 300mg, RFP 450mg, EMB 800mg and PZA 1500mg daily. Blood samples for the measurement of plasma INH(n=15) and RFP(n=17) level were drawn each at 0, 0.5, 1, 1.5, 2, 4, 6, 8 and 12hrs, and urine was also collected. INH and RFP level in the plasma and the urine were measured by high-performance liquid chromatography(HPLC). Pharmacokinetic parameters such as peak serum concentration(Cmax), time to reach to peak serum concentration(Tmax), half-life, elimination rate constant(Ke), total body clearance(CLtot), nonrenal clearance(CLnr), and renal clearance(CLr) were calculated. Results : 1) Pharmacokinetic parameters of INH were as follows: Cmax; $7.63{\pm}3.20{\mu}g/ml$, Tmax; $0.73{\pm}0.22hr$, half-life; $2.12{\pm}0.84hrs$, Ke; $0.83{\pm}0.15hrs^{-1}$, CLtot; $17.54{\pm}8.89L/hr$, CLnr; $14.74{\pm}8.35L/hr$, CLr; $2.79{\pm}1.31L/hr$. 2) Pharmacokinetic parameters of RFP were as follows: Cmax; $8.93{\pm}3.98{\mu}g/ml$, Tmax; $1.76{\pm}1.13hrs$, half-life; $2.27{\pm}0.54hrs$, Ke; $0.32{\pm}0.08hrs^{-1}$, CLtot; $14.63{\pm}6.60L/hr$, CLr; $1.04{\pm}0.55L/hr$, CLnr; $13.59{\pm}6.21L/hr$. 3) While the correlation between body weight and Cmax of INH was not statistically significant (r=-0.514, p value>0.05), Cmax of RFP was significantly affected by body weight of the patients(r=-0.662, p value<0.01). Conclusion : In Korean patients with tuberculosis, 300mg of INH will be sufficient to reach the ideal peak blood level even in the patients over 50kg of body weight However, 450mg of RFP will not be the adequate dose in the patients who weigh over 50~60kg.